Myriad Genetics | MYGN - Current Assets



Myriad Genetics reported $287.2M in Current Assets for its fiscal quarter ending in March of 2025.


Current Assets Change Date
Agilent USD 4.25B 45M Jul/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Bio-Rad Laboratories USD 2.81B 225.5M Jun/2025
Bruker USD 2.16B 51.2M Jun/2025
Danaher USD 11B 1.47B Jun/2025
Exact Sciences USD 1.51B 137.52M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Illumina USD 2.64B 32M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Mettler Toledo International USD 1.24B 79.67M Jun/2025
Myriad Genetics USD 287.2M 10.8M Mar/2025
Quest Diagnostics USD 2.2B 123M Jun/2025
Quidel USD 1.28B 23.3M Jun/2025
Repligen USD 1.03B 33.58M Mar/2025
Revvity USD 2.24B 81.76M Jun/2025
Standard Biotools USD 506.04M 130.16M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Veracyte USD 414.68M 31.53M Jun/2025
Waters USD 1.78B 42.24M Jun/2025